Białaczka
Leczenie
Leczenie białaczki jest złożone i zależy od typu choroby (ostra lub przewlekła), wieku pacjenta, stanu ogólnego oraz stopnia zaawansowania. Standardowe postępowanie w ostrej białaczce szpikowej (AML) i limfoblastycznej (ALL) obejmuje fazy indukcji remisji (intensywna chemioterapia, np. schemat „7+3” z cytoarabiną i daunorubicyną), konsolidacji oraz podtrzymania, trwające odpowiednio około 6-12 miesięcy dla AML i do 2 lat dla ALL. Terapie celowane, takie jak inhibitory kinazy tyrozynowej (TKI) w CML (np. imatynib, dazatynib) oraz leki celowane na mutacje FLT3 w AML (midostauryna, kwizartynib), znacząco poprawiły wyniki leczenia. Immunoterapia, w tym terapia komórkami CAR-T, stanowi innowacyjne podejście, szczególnie w nawrotowych i opornych przypadkach ALL. Przeszczep komórek macierzystych pozostaje kluczową opcją terapeutyczną dla pacjentów z wysokim ryzykiem lub nawrotową chorobą, choć wiąże się z ryzykiem poważnych powikłań. Radioterapia stosowana jest głównie w specyficznych sytuacjach, takich jak zajęcie OUN czy przygotowanie do przeszczepu.
- Leczenie Białaczki – Podstawowe Zagadnienia
- Główne Metody Leczenia Białaczki
- Leczenie Specyficznych Typów Białaczki
- Leczenie Ostrej Białaczki Szpikowej (AML)
- Leczenie Ostrej Białaczki Limfoblastycznej (ALL)
- Leczenie Przewlekłej Białaczki Szpikowej (CML)
- Leczenie Przewlekłej Białaczki Limfocytowej (CLL)
- Nowoczesne Podejścia do Leczenia Białaczki
- Skutki Uboczne i Opieka Wspomagająca
- Wyniki i Prognozy Leczenia
- Przyszłość Leczenia Białaczki
Leczenie Białaczki – Podstawowe Zagadnienia
Leczenie białaczki zależy od wielu czynników, w tym od typu białaczki (ostra lub przewlekła), wieku pacjenta, ogólnego stanu zdrowia oraz od tego, czy choroba rozprzestrzeniła się na inne narządy lub tkanki. Celem leczenia białaczki jest osiągnięcie remisji i ostatecznie wyleczenie pacjenta. Remisja całkowita oznacza zwykle, że szpik kostny pacjenta nie wykazuje mikroskopowych dowodów choroby, a liczba komórek krwi powróciła do normy1. Nawet przy normalnych wynikach badań krwi, wielu pacjentów z białaczką wymaga ciągłej terapii podtrzymującej, aby utrzymać remisję2.
Fazy Leczenia
Leczenie białaczki często przebiega w kilku fazach, które są zależne od typu białaczki i innych czynników prognostycznych. W przypadku ostrej białaczki szpikowej (AML) i ostrej białaczki limfoblastycznej (ALL) leczenie zazwyczaj składa się z następujących faz12:
- Indukcja remisji – celem jest szybkie zmniejszenie liczby komórek białaczkowych w krwi i szpiku kostnym oraz przywrócenie prawidłowej produkcji komórek krwi. Jest to intensywna faza leczenia, która trwa zwykle około miesiąca12.
- Konsolidacja (intensyfikacja) – ta faza ma na celu zniszczenie pozostałych komórek białaczkowych, które mogą nie być aktywne, ale mogłyby zacząć się ponownie namnażać. Bez leczenia konsolidacyjnego białaczka jest znacznie bardziej prawdopodobna do nawrotu12.
- Podtrzymanie – długotrwała faza leczenia, mająca na celu zapobieganie nawrotom. Leki są zwykle podawane w znacznie niższych dawkach przez długi okres, często latami12.
Całkowite leczenie ALL zwykle trwa około 2 lat, przy czym faza podtrzymania zajmuje większość tego czasu1. Leczenie AML może trwać od 6 do 12 miesięcy1.
Główne Metody Leczenia Białaczki
Chemioterapia
Chemioterapia jest najczęstszą formą leczenia wielu typów białaczki. Wykorzystuje leki do niszczenia komórek białaczkowych lub powstrzymania ich namnażania1. Chemioterapia może być podawana doustnie lub dożylnie i dociera do miejsca nowotworu przez krew, co sprawia, że jest skuteczna w leczeniu nowotworu w różnych częściach ciała1.
W leczeniu ostrej białaczki szpikowej (AML) standardowe leczenie indukcyjne obejmuje kombinację cytoarabiny i daunorubicyny lub idarubicyny1. Ten tzw. schemat „7+3” składa się z 7-dniowego kursu ciągłej infuzji cytoarabiny wraz z 3-dniowym kursem antracykliny1.
W przypadku ostrej białaczki limfoblastycznej (ALL) indukcyjna chemioterapia może zawierać kombinację takich leków jak winkrystyna, prednizon, cyklofosfamid, doksorubicyna i asparaginaza, podawane przez 4-6 tygodni1. W fazie konsolidacji stosuje się często leki takie jak cytarabina i metotreksat1.
Terapia Celowana
Terapia celowana wykorzystuje leki, które są zaprojektowane, aby atakować określone części komórki białaczkowej (jak białko lub gen), które powodują, że przejmują one kontrolę nad normalnymi komórkami krwi1. Leczenie to koncentruje się tylko na zmianach komórkowych, które powodują nowotwór, powodując minimalne, jeśli w ogóle, uszkodzenia zdrowych komórek1.
Różne typy leków celowanych stosowanych w leczeniu białaczki obejmują12:
- Inhibitory kinazy tyrozynowej (TKI) – są preferowanym pierwszym leczeniem dla przewlekłej białaczki limfocytowej (CLL) i przewlekłej białaczki szpikowej (CML), a także niektórych przypadków ALL. Leki te blokują kinazy, białka wewnątrz komórek nowotworowych, które mówią im, aby rosły i rozmnażały się.
- Przeciwciała monoklonalne – to wyprodukowane w laboratorium białka, które przyłączają się do określonej substancji na zewnątrz lub wewnątrz komórek białaczkowych. W zależności od leku, przeciwciała monoklonalne leczą białaczkę poprzez:
- Bezpośrednie zabijanie komórek nowotworowych
- Kierowanie dostarczaniem leków chemioterapeutycznych do komórek nowotworowych
- Dostarczanie substancji radioaktywnej bezpośrednio do komórek nowotworowych (radioimmunologia)
- Aktywowanie białek punktów kontrolnych w komórkach nowotworowych, aby pomóc układowi odpornościowemu w znalezieniu i zniszczeniu chorych komórek
W przypadku przewlekłej białaczki szpikowej (CML) inhibitory kinazy tyrozynowej takie jak imatynib (Gleevec), dazatynib (Sprycel), nilotynib (Tasigna), bozutynib (Bosulif) i ponatynib (Iclusig) są standardowymi metodami leczenia1. W leczeniu AML z mutacją genu FLT3 stosuje się celowaną terapię midostaurinem lub kwizartynibem1.
Immunoterapia
Immunoterapia (terapia biologiczna) wykorzystuje leki do wzmocnienia naturalnych zdolności obronnych organizmu – układu odpornościowego – do walki z białaczką1. Jest to podejście do leczenia białaczki, które modyfikuje układ odpornościowy, aby lepiej celował w komórki nowotworowe i je niszczył1.
Jednym z innowacyjnych rodzajów immunoterapii jest terapia komórkami CAR-T (chimeric antigen receptor), która wykorzystuje komórki odpornościowe pacjenta, modyfikuje je genetycznie do walki z nowotworem i ponownie wprowadza do organizmu1. Terapia ta jest dostępna dla kwalifikujących się pacjentów z niektórymi typami białaczki, zwłaszcza ostrą białaczką limfoblastyczną (ALL)1.
Innym rodzajem immunoterapii jest stosowanie przeciwciał monoklonalnych, które mogą być podawane samodzielnie lub w połączeniu z toksynami czy substancjami radioaktywnymi, aby lepiej kierować leczenie na komórki nowotworowe1.
Przeszczep Komórek Macierzystych
Przeszczep komórek macierzystych (przeszczep szpiku kostnego) może być potrzebny dla pacjentów, których białaczka powróciła lub nie zareagowała na standardowe leczenie. Może być również zalecany, jeśli pacjent ma postać białaczki wysokiego ryzyka, która powoduje, że wyleczenie standardowymi metodami jest mało prawdopodobne1.
Procedura ta pozwala osobie z białaczką na ponowne ustanowienie zdrowego szpiku kostnego poprzez zastąpienie szpiku kostnego z białaczką szpikiem wolnym od białaczki od zdrowej osoby1. Przeszczep może być autologiczny (wykorzystujący własne komórki macierzyste pacjenta) lub allogeniczny (wykorzystujący komórki dawcy)1.
Przeszczep komórek macierzystych jest intensywnym leczeniem, ale jest najlepszą szansą na wyleczenie dla niektórych pacjentów. Skutki uboczne mogą być poważne, a czasem zagrażające życiu1.
Radioterapia
Radioterapia wykorzystuje promieniowanie o wysokiej energii do niszczenia komórek białaczkowych lub opóźniania ich wzrostu. Terapia ta nie jest zwykle stosowana u pacjentów z białaczką, chyba że w specjalnych okolicznościach1:
- Powiększona śledziona (aby zmniejszyć jej rozmiar, gdy zaczyna kolidować z innymi narządami)
- Jako część procesu przeszczepu komórek macierzystych
- Łagodzenie bólu kości u pacjentów, u których kości ulegają uszkodzeniu z powodu komórek nowotworowych w szpiku kostnym
- Leczenie białaczki, która rozprzestrzeniła się do centralnego układu nerwowego (mózgu lub rdzenia kręgowego)1
Leczenie Specyficznych Typów Białaczki
Leczenie Ostrej Białaczki Szpikowej (AML)
AML jest najczęstszym typem ostrej białaczki diagnozowanej u dorosłych1. Pacjenci z AML często rozpoczynają agresywne leczenie wkrótce po otrzymaniu diagnozy. Leczenie może obejmować12:
- Chemioterapię kombinowaną, która obejmuje cytoarabinę
- Chemioterapię kombinowaną z terapią celowaną (midostauryna lub kwizartynib) dla pacjentów, których AML ma mutację w genie FLT3
- Chemioterapię kombinowaną z lekiem celowanym gemtuzumab ozogamicyna
- Chemioterapię dokanałową (cytoarabina lub metotreksat) w przypadku białaczki centralnego układu nerwowego (CNS)
- Opiekę wspierającą
W przypadku osób starszych lub pacjentów, dla których intensywna terapia nie jest zalecana, mogą być rozważane opcje leczenia mniej intensywnego, takie jak terapia azacytydyną i wenetoklaksem1. Wenetoklaks działa na cząsteczkę zaangażowaną w śmierć komórki, promując apoptozę komórek1.
Pacjenci z ostrą białaczką promielocytową (APL), podtypem AML, mogą otrzymać:1:
- Kwas całkowicie trans-retinowy (ATRA) plus trójtlenek arsenu (ATO) w przypadku choroby o niskim do pośredniego ryzyka
- ATRA plus chemioterapia kombinowana, a następnie ATO, w przypadku choroby wysokiego ryzyka
Leczenie Ostrej Białaczki Limfoblastycznej (ALL)
Głównym leczeniem ALL u dorosłych jest zwykle długotrwała chemioterapia. Czasami inne rodzaje leków, takie jak leki celowane lub immunoterapia, mogą być częścią leczenia1.
Leczenie ALL jest złożone i może obejmować1:
- Chemioterapię
- Leczenie przeciwciałami
- Terapię komórkami CAR-T
- Inhibitory kinazy tyrozynowej
- Kortykosteroidy
- Radioterapię
- Przeszczep szpiku kostnego
Ważną częścią leczenia ALL jest profilaktyka centralnego układu nerwowego (CNS) – leczenie, które zmniejsza ryzyko rozprzestrzeniania się białaczki do obszaru wokół mózgu lub rdzenia kręgowego1.
W badaniach z użyciem intensywnej chemioterapii wielolekowej plus dodanie inhibitorów kinazy tyrozynowej dla ALL Ph+ i rytuksymabu dla ALL CD20-dodatniego osiągnięto 3-letnie przeżycie na poziomie 50% lub więcej u dorosłych1.
Leczenie Przewlekłej Białaczki Szpikowej (CML)
Charakterystyczną cechą przewlekłej białaczki szpikowej (CML) jest obecność chromosomu Philadelphia, który zawiera nieprawidłowy gen fuzyjny BCR-ABL11. Leczenie CML zostało zrewolucjonizowane przez wprowadzenie imatynibu (Gleevec) w 2003 roku1.
Imatynib jest lekiem doustnym, który celuje w nieprawidłowe białko związane z chromosomem Philadelphia. Poprzez blokowanie tego białka, lek hamuje proliferację komórek CML i indukuje ich śmierć1.
Inne leki, takie jak dazatynib (Sprycel), nilotynib (Tasigna), bozutynib (Bosulif) i ponatynib (Iclusig), są również dostępne do leczenia pacjentów z CML1.
Pacjenci z CML obecnie mają oczekiwaną długość życia podobną do populacji ogólnej. Mała część pacjentów, którzy byli leczeni przez długi czas i osiągnęli głęboką remisję molekularną, może kwalifikować się do przerwania terapii po omówieniu tego z lekarzem1.
Leczenie Przewlekłej Białaczki Limfocytowej (CLL)
CLL rozwija się wolniej niż inne podtypy białaczkowe, a życie pacjenta jest minimalnie dotknięte przez chorobę1. U osób z CLL i bez objawów można odroczyć leczenie, unikając w ten sposób skutków ubocznych leczenia. Jest bardzo ważne, aby regularnie odwiedzać lekarza, aby leczenie mogło być rozpoczęte, gdy będzie potrzebne1.
- Chemioterapię – leki podawane dożylnie lub doustnie
- Leczenie przeciwciałami monoklonalnymi (rytuksymab) – leki te składają się z przeciwciał zaprojektowanych do atakowania limfocytów B, które przekształciły się w CLL
- Terapię celowaną (idelalizyb, ibrutynib) – leki te blokują enzymy niezbędne do przeżycia komórek CLL
- Leki immunomodulujące (lenalidomid, talidomid) – wpływają na funkcjonowanie układu odpornościowego, utrudniając komórkom CLL przeżycie, rozmnażanie się lub powodowanie objawów
U pacjentów bez del(17p) lub mutacji TP53, niezależnie od tego czy są młodzi czy starsi, zwykle nie reagują dobrze na leczenie lub są skłonni do wczesnych nawrotów, jeśli pierwsze leczenie to jakikolwiek rodzaj chemo-immunoterapii. Leczenie terapiami celowanymi lub przeciwciałami monoklonalnymi generalnie daje lepsze wyniki1.
Nowoczesne Podejścia do Leczenia Białaczki
Terapia Komórkami CAR-T
Terapia komórkami CAR-T (chimeric antigen receptor) to nowy rodzaj immunoterapii, który wykorzystuje komórki T pacjenta (rodzaj białych krwinek), modyfikuje je genetycznie do rozpoznawania i atakowania komórek białaczkowych, a następnie ponownie wprowadza je do organizmu1.
Trzy terapie CAR-T zostały zatwierdzone do leczenia nawrotowej lub opornej na leczenie białaczki prekursorowej limfocytów B1. Terapia CAR-T jest często stosowana u dorosłych, których nowotwór nie reaguje na leczenie lub nawraca1.
Szpitale takie jak OHSU Knight Cancer Institute były jednymi z pierwszych, które oferowały Kymriah, immunoterapię dla ostrej białaczki limfoblastycznej (ALL) i niektórych typów chłoniaków1.
Badania Kliniczne
Badania kliniczne są ważne, ponieważ są jedynym sposobem rozwoju nowych metod leczenia lub poprawy istniejących metod leczenia1. Mogą one zapewnić dostęp do obiecujących terapii, które jeszcze nie są powszechnie dostępne1.
Wiele ośrodków onkologicznych prowadzi badania kliniczne dla wszystkich typów białaczki. Na przykład lekarze w MD Anderson prowadzą badania nad nowymi lekami celowanymi, chemioterapeutykami, immunoterapiami i szczepionkami przeciwnowotworowymi12.
Obecnie prowadzonych jest wiele różnych badań klinicznych testujących lepsze sposoby zapobiegania, wykrywania, diagnozowania i leczenia nowotworów1.
Obserwacja i Oczekiwanie (Watch and Wait)
Niektóre formy białaczki mogą nie wymagać natychmiastowego leczenia lub w ogóle1. W podejściu „obserwacji i oczekiwania” (watch and wait), pacjenci są regularnie monitorowani, ale nie otrzymują aktywnego leczenia, dopóki nie jest to konieczne1.
Takie podejście jest często stosowane w przypadku przewlekłej białaczki limfocytowej (CLL) i niektórych innych przewlekłych białaczek, które rozwijają się powoli1.
Dowody pokazują, że leczenie choroby we wczesnych stadiach nie oferuje żadnych korzyści dla pacjenta1.
Skutki Uboczne i Opieka Wspomagająca
Skutki Uboczne Leczenia
Leczenie białaczki może powodować skutki uboczne, które różnią się w zależności od zastosowanych metod leczenia1. Niektóre skutki uboczne są krótkotrwałe i ustępują po zakończeniu leczenia, ale inne mogą trwać dłużej1.
Chemioterapia może powodować skutki uboczne, takie jak nudności, wymioty, biegunka, zmiany apetytu, zmiany smaku, utrata lub przyrost wagi, gorączka, infekcje, anemia, zawroty głowy, lekkie zawroty głowy i bóle głowy1.
Terapia celowana może również powodować skutki uboczne, ale są one zwykle mniej dotkliwe niż w przypadku chemioterapii konwencjonalnej1.
W przypadku terapii komórkami CAR-T, mogą wystąpić poważne skutki uboczne, w tym zespół uwalniania cytokin i neurologiczne skutki uboczne, które wymagają ścisłego monitorowania1.
Opieka Wspomagająca
Opieka wspomagająca jest ważną częścią leczenia białaczki1. Obejmuje ona leczenie, które ma na celu zapobieganie lub kontrolowanie objawów powodowanych przez białaczkę lub jej leczenie1.
Specjaliści z zakresu onkologii wspierającej mogą pomóc w zarządzaniu fizycznymi, psychologicznymi i emocjonalnymi aspektami życia z białaczką, w tym w zarządzaniu objawami i doradztwie1.
W niektórych ośrodkach, takich jak Rush, dostępna jest rehabilitacja onkologiczna, która zapewnia opiekę i narzędzia potrzebne do zwalczania bólu, zmęczenia i zmniejszonej aktywności podczas i po leczeniu białaczki1.
Wyniki i Prognozy Leczenia
Wyniki leczenia białaczki różnią się znacznie w zależności od typu białaczki, wieku pacjenta, obecności specyficznych mutacji genetycznych i innych czynników1.
Dla ostrej białaczki limfoblastycznej (ALL), niemal 90% dorosłych z diagnozą osiąga całkowitą remisję, co oznacza, że komórki białaczkowe nie są już widoczne w szpiku kostnym pod mikroskopem. Jednakże, pomimo wysokich wskaźników remisji, nawroty wciąż często występują u dorosłych, a wskaźniki przeżycia dla dorosłych pacjentów pozostają na poziomie około 20-40%1.
W przypadku przewlekłej białaczki szpikowej (CML), wprowadzenie inhibitorów kinazy tyrozynowej, takich jak imatynib (Gleevec), znacznie poprawiło prognozy. Pacjenci z CML obecnie mają oczekiwaną długość życia podobną do populacji ogólnej1.
Ogólny 5-letni wskaźnik przeżycia dla białaczki jest szacowany na 63,7%. W miarę pojawiania się nowych, wcześniejszych metod leczenia, współczynnik śmiertelności dla tego typu nowotworów również spada1.
Lepsze leczenie i opieka wspomagająca, postępy w przeszczepianiu komórek macierzystych, badania nad nowymi lekami w badaniach klinicznych, wszystko to przyczynia się do poprawy wyników i jakości życia osób z diagnozą nowotworów krwi1.
Przyszłość Leczenia Białaczki
Leczenie białaczki stale się rozwija, z nowymi lekami i terapiami opracowywanymi i testowanymi w badaniach klinicznych. Terapie celowane i immunoterapie są obecnie badane pod kątem skutecznego leczenia podtypów białaczki we wcześniejszych stadiach1.
Naukowcy w takich ośrodkach jak MD Anderson i Knight Cancer Institute prowadzą badania nad nowymi podejściami do leczenia białaczki, w tym nad nowymi lekami celowanymi, chemioterapeutykami, immunoterapiami i szczepionkami12.
Nowe leki, takie jak wenetoklaks, zatwierdzone w 2020 roku, zmieniają oblicze leczenia białaczki, oferując mniej intensywne opcje dla pacjentów, którzy nie mogą tolerować intensywnej chemioterapii1.
W przyszłości, dzięki dalszym badaniom i innowacjom, możemy spodziewać się jeszcze skuteczniejszych i mniej toksycznych metod leczenia białaczki1.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 6 Innovative Leukemia Treatment Options | MD Anderson Cancer Centerhttps://www.mdanderson.org/cancer-types/leukemia/leukemia-treatment.html
As one of the worlds top cancer centers, MD Anderson brings together internationally renowned physicians with a specialized support team to customize your care. These highly experienced experts communicate and collaborate daily, ensuring you receive comprehensive leukemia treatment. […] The goal of leukemia treatment is to put the disease into remission and ultimately cure the patient. For leukemia, complete remission usually means that the patients bone marrow has no detectable microscopic evidence of the disease and his or her blood counts have returned to normal. […] Even with normal blood counts, many leukemia patients require ongoing maintenance therapy to stay in remission. In some cases, patients in remission undergo a stem cell transplant to maintain remission. […] Patients who remain in continued complete remission for an extended period of time are considered cured. This means they have an extremely low chance of recurrence. The exact amount of time it takes to be considered cured differs among leukemia types, but it is typically measured in years.
- #1 Typical Treatment of Acute Lymphocytic Leukemia (ALL) | American Cancer Societyhttps://www.cancer.org/cancer/types/acute-lymphocytic-leukemia/treating/typical-treatment.html
The main treatment for acute lymphocytic leukemia (ALL) in adults is typically long-term chemotherapy (chemo). Sometimes other types of drugs, such as targeted drugs or immunotherapy, might be part of the treatment as well. […] In recent years, doctors have begun to use more intensive treatments, which has led to more leukemias going into remission. But this is also more likely to cause side effects, such as low white blood cell counts. People may need to get other drugs to help prevent or treat these side effects. […] Treatment of ALL typically takes place in 3 phases: Induction (remission induction), Consolidation (intensification), Maintenance. […] The total treatment usually takes about 2 years, with the maintenance phase taking up most of this time. Treatment may be more or less intense, depending on the subtype of ALL and other prognostic factors.
- #1 Acute lymphocytic leukemia – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/acute-lymphocytic-leukemia/diagnosis-treatment/drc-20369083
In general, treatment for acute lymphocytic leukemia falls into separate phases: […] The purpose of the first phase of treatment is to kill most of the leukemia cells in the blood and bone marrow and to restore normal blood cell production. […] Also called post-remission therapy, this phase of treatment is aimed at destroying any remaining leukemia in the body. […] The third phase of treatment prevents leukemia cells from regrowing. The treatments used in this stage are usually given at much lower doses over a long period of time, often years. […] During each phase of therapy, people with acute lymphocytic leukemia may receive additional treatment to kill leukemia cells located in the central nervous system. In this type of treatment, chemotherapy drugs are often injected directly into the fluid that covers the spinal cord.
- #1 Typical Treatment of Acute Lymphocytic Leukemia (ALL) | American Cancer Societyhttps://www.cancer.org/cancer/types/acute-lymphocytic-leukemia/treating/typical-treatment.html
Treatment needs to be given either to keep the leukemia cells from spreading to the CNS (CNS prophylaxis), or to treat the leukemia if it has already spread to the CNS. […] If the leukemia goes into remission, the next phase often consists of another fairly short course of chemo, using many of the same drugs that were used for induction therapy. […] After consolidation, people generally get maintenance chemotherapy with methotrexate and 6-mercaptopurine (6-MP). […] In general, about 80% to 90% of adults will have complete remissions at some point during these treatments. […] If the leukemia is refractory that is, if it doesn’t go away with the first treatment (which happens in about 10% to 20% of people with ALL) then newer or more intensive doses of chemo drugs may be tried, although they are less likely to work. […] At some point, it may become clear that further treatment, even in clinical trials, is extremely unlikely to cure the leukemia. At this time, the focus of treatment may shift to controlling the leukemia and its symptoms for as long as possible, rather than trying to cure it.
- #1 How We Treat Acute Myeloid Leukemia | Dana-Farber Cancer Institutehttps://www.dana-farber.org/cancer-care/types/acute-myeloid-leukemia/treatment
As a highly specialized center within Dana-Farber Brigham Cancer Center’s Center for Hematologic Oncology, the Adult Leukemia Program focuses on the distinct needs of leukemia patients. […] Your care will involve the latest treatments currently available, including the opportunity to participate in clinical trials of new therapies based on research in our laboratories and elsewhere in the field of leukemia treatment. […] We take a very personalized approach to your care. Using the most advanced sequencing techniques, we identify the mutations specific to your disease in order to plan the best treatment for you and identify if a clinical trial may be appropriate. […] Treatment for AML is a long-term process. Chemotherapy and other treatment for the disease may take 6 to 12 months to complete.
- #1 Leukemia: Symptoms, Signs, Causes, Types & Treatmenthttps://my.clevelandclinic.org/health/diseases/4365-leukemia
Leukemia starts when the DNA of a single cell in your bone marrow changes (mutates) and cant develop and function normally. Treatments for leukemia depend on the type of leukemia you have, your age and overall health, and if the leukemia has spread to other organs or tissues. […] Treatments for leukemia depend on the type of leukemia you have, your age and overall health, and if the leukemia has spread to other organs or tissues. […] Common treatments often include a combination of the following: Chemotherapy is the most common form of leukemia treatment. It involves using chemicals to kill leukemia cells or keep them from multiplying. […] Immunotherapy (biologic therapy): This treatment uses certain drugs to boost your bodys defense system your immune system to fight leukemia. […] Targeted therapy: This treatment uses drugs designed to attack specific parts of a leukemia cell (like a protein or gene) that are causing them to overtake normal blood cells.
- #1https://www.americanoncology.com/cancer-we-treat/treatment/leukemia
The treatment of leukemia depends on the stage and spread of cancer cells However, a patient may be treated through the following methods: […] Chemotherapy is a treatment technique that uses drugs to kill cancerous cells. The drugs may be delivered through the mouth or as an intravenous injection. The drugs reach the site of cancer through blood; thus, the therapy effectively treats cancer in different parts of the body. Previously, chemotherapy was the mainstay of treatment for leukemia. However, with the introduction of newer effective therapies, chemotherapy is generally used in specific situations, such as when patients fail to respond to newer therapies or during stem cell transplants. The drugs may be used alone or in combination, based on the types of leukemia. […] Radiation therapy involves using high-energy radiation to kill cancer cells or delay their growth. Radiation therapy is not usually in patients with leukemia. It is applied only during special circumstances, such as the swollen spleen (to shrink the size of the spleen when it starts interfering with other organs). It is also a part of the stem cell transplantation process and relieves bone pain in patients in which the bone gets damaged due to cancerous cells in the bone marrow.
- #1 Treatment for Acute Myeloid Leukemia (AML) | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/types/leukemias/treatment/acute-myeloid-leukemia
Leukemia and Other Blood Cancers More About Leukemia and Other Blood Cancers Types of Leukemia […] The standard treatments for acute myeloid leukemia (AML) include chemotherapy and stem cell transplant, also called a bone marrow transplant. Radiation therapy is sometimes used as well. […] Treatment for AML is typically divided into two phases: remission induction therapy and postremission therapy. […] The goal of the remission induction phase is to bring on a remission. In this state, there is no visible evidence of cancer and blood counts are normal. Most people take two drugs during this phase: cytarabine (Cytosar-U) and daunorubicin (Cerubidine) or idarubicin (Idamycin PFS). […] In postremission therapy, people are treated to eliminate any remaining leukemia cells. This may consist of cytarabine given alone in higher doses.
- #1 Leukemia – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK560490/
Standard therapy for AML is well known as the '7+3′ regimen, which includes a 7-day course of cytarabine continuous infusion with a 3-day course of an anthracycline (either daunorubicin or idarubicin). […] CML is one of the first cancers revolutionized by utilizing targeted therapy with Ph chromosome targeting TKIs. […] CLL runs its course in a more indolent fashion than all the other leukemic subtypes, with the patient’s lifespan minimally impacted by the disease.
- #1 Acute Lymphoblastic Leukemia (ALL) Treatment Protocols: Treatment Protocolshttps://emedicine.medscape.com/article/2004705-overview
Treatment protocols for acute lymphoblastic leukemia (ALL) are provided below, including general treatment recommendations and commonly used treatment recommendations, as well as information on the following: […] The treatment regimen for patients with ALL is determined primarily by the Philadelphia chromosome status of the leukemia and the age of the patient. Patients with Philadelphia chromosome-positive (Ph+) ALL receive a tyrosine kinase inhibitor (TKI) in combination with chemotherapy. […] Treatment recommendations for patients who are diagnosed with ALL include induction, consolidation, and maintenance therapy along with CNS prophylaxis, as follows: […] Patients receive induction therapy with combinations of drugs, including vincristine, prednisone, cyclophosphamide, doxorubicin, and asparaginase, which are given over 4-6 weeks.
- #1 Acute Lymphoblastic Leukemia (ALL) Treatment Protocols: Treatment Protocolshttps://emedicine.medscape.com/article/2004705-overview
Patients then receive consolidation (intensification) with multiagent therapy, including cytarabine and methotrexate; there is no role for radiation or surgical treatment in the induction phase. […] Maintenance therapy includes 6-mercaptopurine, methotrexate, steroids, and vincristine; intrathecal methotrexate is administered throughout. […] Newer studies with intensive multiagent chemotherapy plus the addition of TKIs for Ph+ ALL and rituximab for CD20-positive ALL have resulted in 3-year survivals of 50% or more in adults. […] Chemotherapy plus TKI, followed by allogeneic stem cell transplantation if an appropriate donor is available; if transplantation is not feasible, continue multiagent chemotherapy and a TKI. […] Stem cell transplantation represents the most intensive postremission therapy and potentially increases a patient’s chance for cure.
- #1 Targeted Therapy — Leukemia Research Foundationhttps://leukemiarf.org/patients/treatment/options/targeted-therapy/
Targeted therapy drugs are a first line of treatment for certain types of leukemia. These medicines find and target specific proteins or changes in cells that cause leukemia. Unlike chemotherapy (which affects healthy and diseased cells), targeted therapy focuses only on the cell changes that cause the cancer. The drugs cause minimal, if any, damage to healthy cells. […] There are different types of targeted therapy drugs for leukemia. These lab-made drugs can find specific substances in leukemia cells, such as proteins or genetic (DNA) changes. The drugs then damage or destroy the diseased cells. Some targeted therapy drugs are also an immunotherapy. The drugs bolster the immune systems ability to find and destroy the targeted leukemia cells. […] Leukemia cells must have a specific gene change or mutation for targeted therapy to work. The drug targets the changed gene. A genetic test (a type of blood test) checks for these cell changes to determine whether targeted therapy is a treatment option.
- #1 Targeted Therapy — Leukemia Research Foundationhttps://leukemiarf.org/patients/treatment/options/targeted-therapy/
Targeted therapy may be an effective first treatment for people who have: Acute lymphoblastic lymphoma (ALL), including B-ALL and T-ALL; Chronic lymphocytic leukemia (CLL); Chronic myeloid leukemia (CML); NPM1-mutated AML. […] People with other types of leukemia may receive targeted therapies when chemotherapy isn’t effective. Or they may get targeted therapy along with other leukemia treatments. […] Types of targeted therapy drugs for leukemia include: Tyrosine kinase inhibitors (TKIs); Monoclonal antibodies. […] TKIs are the preferred first treatment for CLL and CML, as well as some cases of ALL. These oral drugs block kinases, the proteins inside cancer cells that tell them to grow and reproduce. Some proteins allow cancerous cells to survive longer than they should. TKIs interfere with cell communication. They stop leukemia cells from multiplying and cause the cells to die.
- #1 Leukemia Treatmenthttps://www.froedtert.com/leukemia
Early-stage CLL does not need treatment. We will monitor you closely through regular blood tests and physician visits. Treatment starts when the disease begins to progress. Indications to treat include a rapid increase in abnormal cells (doubling in less than six months) and the development of symptoms such as anemia, low platelets, fever, night sweats and weight loss. […] CML treatment was revolutionized with the introduction of imatinib (Gleevec) in 2003. Imatinib is an oral drug that targets the abnormal protein associated with the Philadelphia chromosome. By blocking this protein, the drug inhibits proliferation of CML cells and induces them to die. Other drugs such as dasatinib (Sprycel), nilotinib (Tasigna), bosutinib (Bosulif) and ponatinib (Iclusig) are also available to treat patients with CML. […] Patients with CML currently have a life expectancy similar to the general population. A small proportion of patients who have been on treatment for a long time and have achieved a deep molecular remission may be eligible to discontinue therapy after discussion with their physician.
- #1 Acute Myeloid Leukemia Treatment – NCIhttps://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq
Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. […] There are different types of treatment for people with acute myeloid leukemia (AML). […] The treatment of AML usually has two phases. […] The following types of treatment are used: Chemotherapy, Radiation therapy, Chemotherapy with stem cell transplant, Targeted therapy, Other drug therapy. […] Standard treatment of untreated acute myeloid leukemia (AML) during the remission induction phase depends on the subtype of AML and may include: combination chemotherapy that includes cytarabine, combination chemotherapy with targeted therapy (midostaurin or quizartinib), for people whose AML has a mutation in the FLT3 gene, combination chemotherapy with the targeted therapy drug gemtuzumab ozogamicin, intrathecal chemotherapy (cytarabine or methotrexate), for central nervous system (CNS) leukemia, supportive care.
- #1 8 Leukemia Treatment Options You Should Know | MyLeukemiaTeamhttps://www.myleukemiateam.com/resources/treatments-for-leukemia
Immunotherapy is an approach to treating leukemia that modifies your immune system to be better at targeting and destroying cancer cells. […] Hematopoietic stem cell transplants (formerly called bone marrow transplantation) are sometimes used to treat people with leukemia. […] Radiation therapy (also known as radiotherapy) is not a common treatment in most cases of leukemia. […] Some people with leukemia participate in clinical trials. Clinical trials contribute to cancer research and may provide access to new treatments for leukemia not yet available to everyone. […] Some chronic forms of leukemia, including many cases of CLL/SLL, may not require treatment right away. Instead, doctors may recommend a watch-and-wait approach, also known as watchful waiting. […] Whether or not you’re actively treating your leukemia, making changes to improve your overall health can help you have a better quality of life and may even increase your treatment options for leukemia. […] More effective treatments for leukemia have increased survival rates and rates of remission over the past 10 years. Whether a case of leukemia is curable or not depends on many factors. Your health care team can best advise you on the most effective treatment to try to achieve long-term remission.
- #1 Acute lymphocytic leukemia – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/acute-lymphocytic-leukemia/diagnosis-treatment/drc-20369083
A bone marrow transplant, also known as a stem cell transplant, may be used as consolidation therapy or for treating relapse if it occurs. This procedure allows someone with leukemia to reestablish healthy bone marrow by replacing leukemic bone marrow with leukemia-free marrow from a healthy person. […] A specialized treatment called chimeric antigen receptor (CAR)-T cell therapy takes your body’s germ-fighting T cells, engineers them to fight cancer and infuses them back into your body. […] Clinical trials are experiments to test new cancer treatments and new ways of using existing treatments. While clinical trials give you or your child a chance to try the latest cancer treatment, the benefits and risks of the treatment may be uncertain. Discuss the benefits and risks of clinical trials with your doctor.
- #1 Leukemia Treatment Center | Knight Cancer Institute | OHSUhttps://www.ohsu.edu/knight-cancer-institute/leukemia
Patients who come to the Knight Cancer Institute for leukemia treatment receive the latest treatments from a team of providers. […] The OHSU Knight Cancer Institute is a world leader in treating leukemia. […] Dr. Druker played a central role in developing Gleevec, a daily pill for chronic myeloid leukemia (CML) that has saved tens of thousands of lives. […] We offer you: […] The latest immunotherapies for blood cancers, including leukemia. […] In addition to work on Gleevec and many other breakthroughs, our researchers helped develop immunotherapies for blood cancers. OHSU was the first hospital in the Northwest to offer Kymriah, an immunotherapy for acute lymphoblastic leukemia (ALL) and types of lymphoma. […] OHSU scientists, working with the Leukemia Lymphoma Society and other universities across the U.S., are studying acute myeloid leukemia (AML) at the molecular level.
- #1 Leukemia Treatment Options | Cancer Support Communityhttps://www.cancersupportcommunity.org/article/leukemia-treatment-options
People with chronic myeloid leukemia and some with acute lymphoblastic leukemia may receive targeted therapies or drugs that block the growth of leukemia cells. Targeted therapies treat the cancer cells with less harm to normal cells. Imatinib (Gleevec) was the first targeted therapy approved for chronic myeloid leukemia, but other drugs are now used as well. […] This treatment improves the bodyâs natural defenses against leukemia. One type is a substance called a monoclonal antibody. It is given by IV infusion and binds to leukemia cells, killing them or helping the immune system destroy them. […] Radiation therapy uses high-energy rays to kill leukemia cells. Some people receive radiation from a large machine aimed at the spleen, brain or other parts of the body where leukemia cells have collected. Others may receive radiation that is directed to the whole body.
- #1 6 Innovative Leukemia Treatment Options | MD Anderson Cancer Centerhttps://www.mdanderson.org/cancer-types/leukemia/leukemia-treatment.html
A stem cell transplant may be needed for patients whose leukemia has returned or has not responded to standard treatments. It may also be recommended if the patient has a high-risk form of leukemia that would make a cure with standard treatments unlikely. This treatment can be physically challenging, so it is typically not given to patients who are older or otherwise unhealthy. […] In leukemia, for example, we look for response after chemotherapy treatment by looking under the microscope for cancer cells present in a bone marrow biopsy. When there are no cancer cells present, and the bone marrow is making normal cells, we call that a complete response. […] However, we know that if we dont do further treatment, a portion of these patients will experience a relapse. That means there were some leukemia cells hiding that we werent able to detect under the microscope.
- #1 Treatment for Acute Myeloid Leukemia (AML) | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/types/leukemias/treatment/acute-myeloid-leukemia
Some people with AML undergo either an autologous transplant or an allogeneic transplant. An autologous transplant uses a patients own blood stem cells, and an allogeneic transplant uses blood or marrow stem cells donated by someone else. […] In rare instances, AML can spread to the brain or other parts of the nervous system. […] You may have the opportunity to participate in a clinical trial. These studies investigate new approaches to killing tumor cells directly, inhibiting the bodys production of substances that promote their growth, or enhancing the immune response against leukemia cells. […] MSK researchers are conducting clinical trials targeting specific genetic mutations or chromosomal abnormalities commonly found in AML. […] Targeted therapies often have fewer side effects than conventional chemotherapy drugs.
- #1 Treatment options for acute myeloid leukaemia (AML) | Cancer Research UKhttps://www.cancerresearchuk.org/about-cancer/acute-myeloid-leukaemia-aml/treating-aml/decisions-about-your-treatment
The aim of this phase is to get rid of all the leukaemia cells. In remission there is no sign of the leukaemia in your blood or bone marrow. […] When there is no sign of the leukaemia (remission) you have consolidation treatment. This aims to lower the risk of leukaemia coming back. […] A stem cell transplant is an intensive treatment but is the best chance of cure for some. Side effects can be severe and sometimes life threatening. […] Not everyone with AML will have maintenance treatment. The aim is to keep the AML away in the long term. This is usually for people with a high risk of it coming back. […] Non intensive treatment aims to control your leukaemia for as long as possible. […] Non intensive treatment is usually a combination of a chemotherapy drug with a targeted cancer drug.
- #1 Leukemia Treatment | Fox Chase Cancer Center – Philadelphia PAhttps://www.foxchase.org/clinical-care/conditions/leukemia/leukemia-treatment
When treating patients with leukemia, the best outcomes result from a multidisciplinary approach to care. At Fox Chase Cancer Center, our team of medical oncologists, radiation oncologists, radiologists, and hematopathologists work together seamlessly to diagnose your cancer and help you understand your treatment options. […] Treatment options for leukemia available at Fox Chase include: […] Acute myeloid leukemia (AML) is the most common type of acute leukemia diagnosed in adults. AML patients often begin aggressive treatment soon after receiving a diagnosis, and their treatment may include chemotherapy, targeted therapy, and/or bone marrow transplantation. […] Chemotherapy drugs disrupt the life cycle of cancer cells by altering the instructions that tell them how and when to grow and divide.
- #1 Acute Myeloid Leukemia Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK65939/
Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. […] The treatment of AML usually has two phases. […] Different types of treatments are available for people with AML. You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment. […] The following types of treatment are used: Chemotherapy, Radiation therapy, Chemotherapy with stem cell transplant, Targeted therapy, Other drug therapy. […] The prognosis and treatment options for AML depend on: the person’s age, whether the leukemia has spread to the CNS, whether the patient has a systemic infection at the time of diagnosis, whether the patient has a very high white blood cell count at the time of diagnosis, the subtype of AML, whether the patient received chemotherapy or radiation therapy in the past to treat a different cancer, whether there is a history of a blood disorder such as myelodysplastic syndrome, whether the cancer has been treated before or recurred (come back).
- #1 How We Treat Acute Myeloid Leukemia | Dana-Farber Cancer Institutehttps://www.dana-farber.org/cancer-care/types/acute-myeloid-leukemia/treatment
The treatment of adult AML is usually done in phases. In addition to standard approaches outlined here, we offer clinical trial options for patients in all phases of treatment. […] Traditionally, this was the phase of your therapy when you get intensive chemotherapy. However, with more effective frontline treatment options now available, the remission induction phase may now include intensive or less intensive treatments to get patients into remission. […] There are also treatment options for patients not recommended for intensive therapy. For these patients, azacitidine and venetoclax-based treatments may be considered. […] The goal of consolidation therapy is to prevent relapse by killing any remaining leukemia cells that may not be active but could begin to regrow. […] Some patients, including older adults who would not benefit from intensive initial chemotherapy, may benefit from an allogeneic stem cell transplant as part of initial treatment or as part of treatment for relapsed disease.
- #1 The Latest Treatment Options for Acute Myeloid Leukemia – InventUMPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonhttps://news.med.miami.edu/the-latest-treatment-options-for-acute-myeloid-leukemia/
Recently approved drugs are rapidly changing the treatment of patients with acute myeloid leukemia. […] New drugs are beginning to brighten the outlook. […] The approval of the drug venetoclax in 2020, and similar drugs after that, enabled physicians to offer such patients a less harsh option. Venetoclax targets a molecule involved in cell death, promoting cell apoptosis. It is typically combined with the older chemotherapy drug azacitidine. […] Patients generally better tolerate the azacitidine-venetoclax combination than traditional chemotherapy and often stay on it for the rest of their lives. […] Since weâve introduced this combination, more patients are getting treated, more patients are getting treated as outpatients closer to their homes, and the people who are being treated are living longer.
- #1 Acute Myeloid Leukemia Treatment – NCIhttps://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq
Treatment of newly diagnosed acute promyelocytic leukemia (APL) may include: all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO), for low-risk to intermediate-risk disease, ATRA plus combination chemotherapy, followed by ATO, for high-risk disease. […] Treatment for acute myeloid leukemia may cause side effects. […] Follow-up care may be needed.
- #1 Leukemia Treatment | Fox Chase Cancer Center – Philadelphia PAhttps://www.foxchase.org/clinical-care/conditions/leukemia/leukemia-treatment
Targeted therapy is a type of systemic therapy that works to stop cancer cells from reproducing and growing. […] A bone marrow transplant, also called a stem cell transplant, infuses healthy cells into the body to replace damaged or diseased bone marrow. […] Chronic lymphocytic leukemia (CLL) is the most common type of chronic leukemia diagnosed in adults. […] When treatment is needed, patients may receive targeted therapy, antibody treatment, chemotherapy, or a bone marrow transplant. […] The hallmark feature of chronic myeloid leukemia (CML) is the presence of the Philadelphia chromosome, which contains the abnormal fusion gene BCR-ABL1. […] Treatment for acute lymphocytic leukemia (ALL) is complex. Options include chemotherapy, antibody treatment, CAR T-cell therapy, tyrosine kinase inhibitors, corticosteroids, radiation therapy, and bone marrow transplantation. […] An allogeneic transplant may be a treatment option depending on the type of ALL the patient has.
- #1 Typical Treatment of Acute Lymphocytic Leukemia (ALL) | American Cancer Societyhttps://www.cancer.org/cancer/types/acute-lymphocytic-leukemia/treating/typical-treatment.html
Even if leukemia cells aren’t found in the CSF at diagnosis, it’s possible that they might spread there later on. This is why an important part of treatment for ALL is central nervous system (CNS) prophylaxis treatment that lowers the risk of the leukemia spreading to the area around the brain or spinal cord. […] The goal of induction chemo is to get the leukemia into remission (complete remission). This means that leukemia cells are no longer found in bone marrow samples (on a bone marrow biopsy), the normal marrow cells return, and the blood counts return to normal levels. […] Induction chemo usually lasts for a month or so. […] Most often, leukemia goes into remission with induction chemotherapy. But because leukemia cells may still be hiding somewhere in the body, further treatment is needed.
- #1 Leukemia Treatment Options | Cancer Support Communityhttps://www.cancersupportcommunity.org/article/leukemia-treatment-options
Follow-up care depends on the type of leukemia and treatments used. It is very important to have a doctor check for recurrence of cancer. Even when the cancer seems to be completely destroyed, the disease sometimes returns after treatment. Follow-up care may include physical exams, blood tests, cytogenetics, x-rays, bone marrow aspiration or spinal taps. […] Treatments Used For Leukemia […] People with chronic lymphocytic leukemia and no symptoms may be able to put off treatment, thereby avoiding the side effects of treatment. It is very important to see a doctor regularly so that treatment can be started when needed. Watchful waiting comes with some risk; it may reduce the chance to control leukemia before it gets worse. […] This common treatment uses drugs to kill cancer cells. Depending on the drug, chemotherapy can be given by mouth, into a vein through an IV, through a catheter or directly into the cerebrospinal fluid. Chemotherapy kills fast-growing leukemia cells, but the drug can also harm normal cells that divide rapidly, often causing side effects.
- #1 Medical Treatments for Chronic Lymphocytic Leukemia | NYU Langone Healthhttps://nyulangone.org/conditions/chronic-lymphocytic-leukemia/treatments/medical-treatments-for-chronic-lymphocytic-leukemia
Medical Treatments for Chronic Lymphocytic Leukemia […] NYU Langone doctors can often effectively manage chronic lymphocytic leukemia (CLL) using a combination of medical therapies. The result can be remission, when the signs and symptoms of a disease disappear. This means that the amount of cancerous lymphocytes is reduced so significantly that these cells are no longer detectable in the blood and bone marrow. […] […] Our doctors make decisions about the type of therapy you should receive and how often you should receive it based on the genetic features of the cancer cells, which are identified in diagnostic tests. Typically, people with chronic lymphocytic leukemia are treated with a combination of therapies. […] Chemotherapy, in which drugs are used to destroy cancer cells throughout the body, is usually given through a needle into a vein in an intravenous (IV) infusion or by mouth. Treatment schedules vary, but chemotherapy is often given several days a week for three or four weeks in a row. Several of these treatment cycles are usually needed, each followed by a break or rest period. […]
- #1 https://www.lls.org/leukemia/chronic-lymphocytic-leukemia/treatment/chemotherapy-and-drug-therapyhttps://www.lls.org/leukemia/chronic-lymphocytic-leukemia/treatment/chemotherapy-and-drug-therapy
Beginning Treatment for CLL […] Treatment of CLL is started when symptoms develop that are associated with active disease. Before starting treatment, it is important to have another FISH test to see if there are any changes to the genes and/or chromosomes of the CLL cells. […] Because CLL is typically a disease of older people, the doctor will also evaluate a patients fitness and identify other medical conditions or problems that may affect CLL treatment. […] Patients without del(17p) or TP53 mutations, whether young or older, typically do not respond well to treatment or are likely to have early relapses if the first treatment is any type of chemo-immunotherapy. Treatment with targeted therapies or monoclonal antibodies generally has better results. […] These treatments are designed to target (attack) specific substances on cancer cells with less harm to normal, healthy cells. Most targeted therapies for CLL are given as pills and, in general, have milder side effects than chemotherapy.
- #1 Leukemia: Symptoms, Signs, Causes, Types & Treatmenthttps://my.clevelandclinic.org/health/diseases/4365-leukemia
Radiation therapy: This treatment uses strong energy beams or X-rays to kill leukemia cells or stop them from growing. […] Hematopoietic cell transplant (stem cell or bone marrow transplant): This treatment replaces the cancerous blood-forming cells killed by chemotherapy and/or radiation therapy with new, healthy hematopoietic cells. […] Chimeric antigen receptor (CAR) T-cell therapy: This is a novel type of therapy that takes your bodys infection-fighting T-cells (T-cell or T-lymphocyte is a type of immune cell), engineers them to fight leukemia cells and infuse them back into your body. […] Depending on your treatment plan, you may receive ongoing leukemia treatments long-term or treatment in phases. […] The goal is to kill as many leukemia cells as possible in your blood and bone marrow to achieve remission.
- #1 Acute Lymphoblastic Leukemia (ALL) Treatment Protocols: Treatment Protocolshttps://emedicine.medscape.com/article/2004705-overview
The prognosis for patients who experience relapse after front-line therapy is poor, with very few patients surviving long term. The best outcome is obtained if patients achieve a second remission and then proceed to allogeneic stem cell transplantation. […] Clofarabine is a purine nucleoside metabolic inhibitor approved for the treatment of pediatric patients aged 1-21 years with relapsed or refractory ALL after at least two prior regimens. […] Blinatumomab, a bispecific T-cell engager (BiTE) antibody, is approved for Ph- relapsed or refractory B-cell ALL; treatment cycles consist of 4 weeks continuous IV infusion with at least a 2-week treatment-free interval between cycles. […] Three chimeric antigen receptor (CAR) T-cell therapies have been approved for treatment of relapsed or refractory B-cell precursor ALL.
- #1 Leukemia Treatment Options — Leukemia Research Foundationhttps://leukemiarf.org/patients/treatment/options/
CAR T-cell therapy is often used in adults whose cancer doesn’t respond to treatment or returns. […] CAR T-cell therapy is not right for all leukemias, and is only available to children through clinical trials. […] Stem cell transplants are used to replace stem cells when the bone marrow has been destroyed by disease, chemotherapy, or radiation. […] This is called „watch and wait,” „active surveillance,” or „watchful waiting.” […] Evidence shows treating the disease in the early stages doesn’t offer any benefit to the patient. […] Clinical trials available at some medical centers may give eligible patients access to promising treatments not widely available.
- #1 Treatments For leukaemia | Leukaemia UKhttps://www.leukaemiauk.org.uk/about-leukaemia/treatments/
Stem cell transplantation (SCT), also known as a bone marrow transplant, is a procedure in which a patient receives healthy stem cells to replace faulty stem cells. […] Stem cell transplants can be used to treat certain types of cancer, such as leukaemia, lymphoma, myeloma, and neuroblastoma, and other blood and immune system diseases that affect the bone marrow. […] Radiotherapy can be used to treat all types of blood cancer but more commonly used to treat Hodgkin lymphoma or Non-Hodgkin lymphoma. […] Clinical trials are important, because they are the only way to develop new treatments or improve existing treatments.
- #1 Leukemiahttps://medschool.cuanschutz.edu/colorado-cancer-center/for-patients-families/cancers-we-treat/leukemia
The CU Cancer Center is home to world-class leukemia care teams. The teams research has led to many different breakthroughs in how to treat cancers that affect the blood and bone marrow. […] Treatments for leukemia are tailored to each patient and depend on the patients age, overall health, type of leukemia, and diagnosis stage. […] Chemotherapy uses chemicals given in pill form, through an IV into a vein or central line, or given in shots, to kill leukemia cells or stop them from dividing. Chemotherapy is the most common form of treatment for leukemia and consists of cycles of treatment and rest days. […] Radiation is a treatment that uses X-rays or other strong beams of energy to damage leukemia cells and stop them from growing. […] Targeted drug therapy focuses on specific abnormalities within leukemia cells. These drugs work by blocking the leukemia cells ability to divide or by cutting off blood supply to the cells.
- #1 Treatment options | Cancer Australiahttps://www.canceraustralia.gov.au/cancer-types/leukaemia/treatment-options
Immunotherapy involves treatment with medicines that boost the ability of the immune system to attack cancer cells. […] Treatment for leukaemia often lasts for years. […] If leukaemia treatment is unsuccessful, palliative treatment to control the symptoms of the disease may be the best option. […] Treatment options for recurrent leukaemia include further chemotherapy, possibly using different medicines or higher doses, targeted treatment with blinatumomab (for some types of ALL) or a stem cell transplant. […] Some forms of leukaemia may not need to be treated straight away, or at all. […] Other treatments may be used for different types of leukaemia, but these are not used as often as the main treatments.
- #1 Leukaemia – what is it, symptoms and treatment | Blood Cancer UKhttps://bloodcancer.org.uk/understanding-blood-cancer/leukaemia/
The treatment you have will depend on the type of leukaemia you have, as well as other factors. […] We have more specific information about treatment if you choose a type of leukaemia above. […] These are some common treatments. You might have these treatments on their own or in combination: […] Active monitoring (watch and wait): Some people with slow-developing blood cancers dont need treatment straight away this is called active monitoring or watch and wait. […] Chemotherapy uses drugs to kill cancer cells or stop them from growing. […] There are other drug therapies that can be used on their own or with chemotherapy. […] Having a stem cell transplant involves having high doses of chemotherapy to kill the abnormal cells in your bone marrow or lymph nodes, and then receiving new blood stem cells (either your own or from a donor) through a drip. […] There are a number of possible side effects of leukaemia treatment. […] Some side effects are short-term and go away after treatment has finished, but others can last longer.
- #1 Leukemia Symptoms, Diagnosis & Treatments | Rushhttps://www.rush.edu/services/leukemia-care
Yes, leukemia can be cured, but the treatment needed for a cure can be different for everyone and may depend on the type of leukemia. In some cases, a stem cell transplant is needed for a cure. […] Rush works with ReVital Cancer Rehabilitation to provide you with the care and tools you need to address pain, fatigue and decreased activity levels during and after leukemia treatment.
- #1 Treatments for childhood leukemia | Canadian Cancer Societyhttps://cancer.ca/en/cancer-information/cancer-types/leukemia-childhood/treatment
If your child has leukemia, the healthcare team will create a treatment plan just for your child. It will be based on your child’s health and specific information about the leukemia. When deciding which treatments to offer for childhood leukemia, the healthcare team will consider: […] The main treatment for childhood acute lymphocytic leukemia is chemotherapy. […] The main treatment for childhood acute myelogenous leukemia is chemotherapy. […] Chemotherapy is commonly used to treat childhood leukemia. […] Targeted therapy is sometimes used to treat childhood leukemia. […] Immunotherapy is sometimes used to treat childhood leukemia that doesn’t respond to other treatments or comes back after treatment. […] Radiation therapy may be used to treat childhood leukemia. […] Stem cell transplant may be used to treat childhood leukemia. […] Supportive therapy is an important part of childhood leukemia treatment. […] Follow-up after childhood leukemia treatment varies. […] Adjusting to life after treatment for childhood leukemia is different for each child.
- #1 Treatment for acute lymphoblastic leukaemia – NHShttps://www.nhs.uk/conditions/acute-lymphoblastic-leukaemia/treatment/
Acute lymphoblastic leukaemia (ALL) is often treatable. […] Treatment usually needs to start quickly. […] It will usually include steroids and chemotherapy. It may also include targeted medicines, immunotherapy or a stem cell or bone marrow transplant. […] Steroid medicine aims to get rid of the leukaemia cells. […] Chemotherapy uses medicines to kill cancer cells. It’s the main treatment for acute lymphoblastic leukaemia. […] Targeted medicines aim to stop cancer growing. Immunotherapy is where medicines are used to help the immune system kill cancer. […] A stem cell or bone marrow transplant replaces damaged blood cells with healthy ones. […] You may need to have treatment to prevent or control symptoms caused by acute lymphoblastic leukaemia. […] Sometimes acute lymphoblastic leukaemia might be very hard to treat, and it may not be possible to cure the cancer. […] If this is the case, the aim of treatment will be to limit the cancer and its symptoms, and help you live longer.
- #1https://winshipcancer.emory.edu/cancer-types-and-treatments/leukemia/treatment.php
At Winship, we are committed to delivering the most effective leukemia treatment with the fewest possible side effects. […] We have a supportive oncology team of specialized doctors and nurses on staff to help you with the physical, psychological and emotional aspects of living with leukemia, including symptom management and counseling. […] The Emory Bone Marrow and Stem Cell Translant Center the largest and oldest of its kind in Georgia is internationally known for its research and treatment of blood cancers and blood disorders.
- #1 https://www.lls.org/leukemia/acute-lymphoblastic-leukemia/treatment/treatment-outcomeshttps://www.lls.org/leukemia/acute-lymphoblastic-leukemia/treatment/treatment-outcomes
The cure rates and survival outcomes for patients with ALL have improved over the past few decades. Today, nearly 90 percent of adults diagnosed with ALL achieve a complete remission, which means that leukemia cells can no longer be seen in the bone marrow with a microscope. […] Still, despite high remission rates, relapses still commonly occur in adults and survival rates for adult patients remain at approximately 20 to 40 percent. However, these rates can vary significantly, depending on the patients ALL subtype and other prognostic factors. […] Treatment results and outcomes vary among patients. Newer treatment therapies, progress in stem cell transplantation, better supportive care and studies of new drugs in clinical trials are all contributing to improved outcomes and quality of life for people diagnosed with blood cancers.
- #1 Is Leukemia Curable? Research, Treatments, and Morehttps://www.healthline.com/health/leukemia/is-leukemia-curable
Talk to a doctor about the possible side effects of newer forms of immunotherapy or targeted therapy for leukemia. […] The overall 5-year survival rate for leukemia is estimated at 63.7 percent. […] As new, earlier treatments have emerged, the death rate for this type of cancer is also declining. […] Targeted therapies and immunotherapies are currently being researched to effectively treat leukemia subtypes in earlier stages.
- #1 The Latest Treatment Options for Acute Myeloid Leukemia – InventUMPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonhttps://news.med.miami.edu/the-latest-treatment-options-for-acute-myeloid-leukemia/
Patients also undergo a bone marrow biopsy, which is sent to Sylvesterâs pathology department for a battery of tests. Such tests can determine the types of mutations present in the tumor and guide decisions about recommendations for targeted therapies. […] Both Drs. Sekeres and Venugopal credit the strength of the pathology team in helping Sylvester onboard the new treatment approaches, supporting an array of clinical trials and adapting to a fast-changing field. […] Dr. Venugopalâs and Dr. Sekeresâ new review should help physicians at other treatment centers make the best treatment recommendations. […] At Sylvester, the new approaches are already changing patientsâ quality of life. […] If patients need more intensive care or transplantation, they have access to a fully dedicated inpatient leukemia unit in Miami. […] We all work together to make sure not only that patients get the best treatment for their diagnosis, but also the best care.
- #2 6 Innovative Leukemia Treatment Options | MD Anderson Cancer Centerhttps://www.mdanderson.org/cancer-types/leukemia/leukemia-treatment.html
As one of the worlds top cancer centers, MD Anderson brings together internationally renowned physicians with a specialized support team to customize your care. These highly experienced experts communicate and collaborate daily, ensuring you receive comprehensive leukemia treatment. […] The goal of leukemia treatment is to put the disease into remission and ultimately cure the patient. For leukemia, complete remission usually means that the patients bone marrow has no detectable microscopic evidence of the disease and his or her blood counts have returned to normal. […] Even with normal blood counts, many leukemia patients require ongoing maintenance therapy to stay in remission. In some cases, patients in remission undergo a stem cell transplant to maintain remission. […] Patients who remain in continued complete remission for an extended period of time are considered cured. This means they have an extremely low chance of recurrence. The exact amount of time it takes to be considered cured differs among leukemia types, but it is typically measured in years.
- #2 Acute Myeloid Leukemia Treatment – NCIhttps://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq
Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. […] There are different types of treatment for people with acute myeloid leukemia (AML). […] The treatment of AML usually has two phases. […] The following types of treatment are used: Chemotherapy, Radiation therapy, Chemotherapy with stem cell transplant, Targeted therapy, Other drug therapy. […] Standard treatment of untreated acute myeloid leukemia (AML) during the remission induction phase depends on the subtype of AML and may include: combination chemotherapy that includes cytarabine, combination chemotherapy with targeted therapy (midostaurin or quizartinib), for people whose AML has a mutation in the FLT3 gene, combination chemotherapy with the targeted therapy drug gemtuzumab ozogamicin, intrathecal chemotherapy (cytarabine or methotrexate), for central nervous system (CNS) leukemia, supportive care.
- #2 Acute lymphoblastic leukemia treatment – Leukaemia Foundationhttps://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/leukaemia/acute-lymphoblastic-leukaemia/treatment/
Treatment for ALL can be divided into three phases: induction therapy, post-remission (consolidation) therapy, maintenance therapy. […] Soon after you are diagnosed your doctor will need to begin an intensive course of treatment to bring about, or induce, a remission. You will need to be admitted to hospital for this first phase of treatment. […] Soon after induction therapy finishes and remission is achieved, more treatment is required to help destroy any leftover disease in your body. This is important because it helps to prevent the disease from reappearing (relapsing), or spreading to the central nervous system (brain and spinal cord) in the future. […] Maintenance therapy is designed to help keep your disease in remission and prevent it from reappearing (relapsing) in the future. Common maintenance protocols involve chemotherapy tablets â some taken daily and others weekly â and possibly blocks of injections of chemotherapy with courses of cortico-steroids.
- #2 Intensive treatment for AML | Blood Cancer UKhttps://bloodcancer.org.uk/understanding-blood-cancer/leukaemia/acute-myeloid-leukaemia/aml-treatment/intensive/
Consolidation aims to stop the AML coming back by killing any leukaemia cells that may remain. Without consolidation treatment, the AML is much more likely to come back. […] Intensive treatment for AML lasts for several months. […] There are many different drugs that can treat AML, and research continues to find new ones. […] Cytarabine and daunorubicin are both chemotherapy drugs that are given into a vein. […] Gemtuzumab ozogamicin is an antibody drug that can bind specifically to leukaemia cells and destroy them. […] A stem cell transplant involves having cancer treatment to get rid of the leukaemia, before having new stem cells put into your body, which come from somebody else (a donor). […] Maintenance therapy means having more long-term treatment, for one or more years, after you finish consolidation therapy and you are in remission. The aim of maintenance therapy is to further reduce the risk of AML coming back (relapse).
- #2 Targeted Therapy — Leukemia Research Foundationhttps://leukemiarf.org/patients/treatment/options/targeted-therapy/
Monoclonal antibodies are lab-made proteins that attach to a targeted substance outside or inside leukemia cells. You receive this treatment through an IV. Depending on the drug, monoclonal antibodies treat leukemia by: Killing cancer cells directly; Guiding the delivery of chemotherapy drugs to cancer cells, making chemo more effective; Delivering a radioactive substance called an isotope directly into cancer cells (radioimmunotherapy); Activating checkpoint proteins in cancer cells to help the immune system find and destroy the diseased cells. […] Some people who get targeted therapy have few, if any, side effects, while others experience more severe problems. Most side effects go away when treatment stops and healthy cells have time to recover. In the meantime, you can take steps to manage treatment side effects.
- #2 Acute Myeloid Leukemia Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK65939/
Standard treatment of untreated acute myeloid leukemia (AML) during the remission induction phase depends on the subtype of AML and may include: combination chemotherapy that includes cytarabine, combination chemotherapy with targeted therapy (midostaurin or quizartinib), for people whose AML has a mutation in the FLT3 gene, combination chemotherapy with the targeted therapy drug gemtuzumab ozogamicin, intrathecal chemotherapy (cytarabine or methotrexate), for central nervous system (CNS) leukemia, supportive care. […] Treatment of acute myeloid leukemia (AML) during the remission phase depends on the subtype of AML and may include: combination chemotherapy that includes cytarabine, maintenance therapy with midostaurin, for people whose AML has a mutation in the FLT3 gene, maintenance therapy with chemotherapy, high-dose chemotherapy and stem cell transplant using the patient’s stem cells, high-dose chemotherapy, with or without radiation therapy, or reduced-intensity therapy, followed by a stem cell transplant using donor stem cells.
- #2 Medical Treatments for Chronic Lymphocytic Leukemia | NYU Langone Healthhttps://nyulangone.org/conditions/chronic-lymphocytic-leukemia/treatments/medical-treatments-for-chronic-lymphocytic-leukemia
Your doctor may recommend combining chemotherapy drugs with a targeted medication called rituximab, which is in a class of medications called monoclonal antibodies. These medications consist of antibodies or immune system proteins that are designed to attack the B lymphocytes, which are the type of cells that have transformed to chronic lymphocytic leukemia. […] […] Idelalisib is another targeted therapy that your doctor may prescribe with rituximab if the cancer does not respond to or comes back after other therapy. Idelalisib blocks an enzyme found in chronic lymphocytic leukemia cells that is responsible for the cells division and growth. Another medication that may be used is ibrutinib, which blocks a different enzyme necessary for chronic lymphocytic cells to survive. Both of these medications are taken as pills, and while new, they may offer people with chronic lymphocytic leukemia additional therapeutic options.
- #2 Treatment for Acute Myeloid Leukemia (AML) | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/types/leukemias/treatment/acute-myeloid-leukemia
MSK doctors are studying new chemotherapy drugs that may be better at killing leukemia cells or have more effective delivery to leukemia cells. […] Monoclonal antibodies are genetically engineered proteins designed to target specific sites called antigens. […] Researchers at MSK are evaluating vaccines made from protein pieces (peptides) found on AML cells.